Abstract
As is well known, the Covid-19 pandemic has impacted pharmaceutical companies in Indonesia, which have played an active role in handling these extraordinary events. This study aims to determine the effect of company financial performance in terms of profitability ratios, liquidity ratios, and solvency ratios on stock returns in pharmaceutical companies in Indonesia for the 2017-2022 period. A total of eight companies listed on the Indonesia Stock Exchange were examined according to purposive sampling criteria. Observation of data from 48 annual financial reports processed using the Eviews 12 program. The results of this study indicate that Return on Assets (ROA) and Current Assets (CR) have a positive and significant effect on firm value. Earning per Share (EPS) does not affect Stock Return. Meanwhile, the Debt to Equity Ratio significantly negatively affects stock returns.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JOURNAL OF ECONOMICS, FINANCE AND MANAGEMENT STUDIES
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
